Effects of low-dose hydroxychloroquine on expression of phosphorylated Akt and p53 proteins and cardiomyocyte apoptosis in peri-infarct myocardium in rats

Experimental and Clinical Cardiology

Volumn 18, Issue 2, 2013, Pages

  Zhou, Jing ^a   Li, Gang ^a   Wang, Zhi Hua ^a   Wang, Li Ping ^a   Dong, Pu Jiang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Akt (protein kinase B); Cardiomyocyte apoptosis; Hydroxychloroquine (HCQ); Myocardial infarction (MI); P53 (protein 53)

Indexed keywords

HYDROXYCHLOROQUINE; PROTEIN KINASE B; PROTEIN P53; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE CELL; HEART PROTECTION; HEART RATE; LOW DRUG DOSE; M MODE ECHOCARDIOGRAPHY; MALE; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TREATMENT DURATION; WESTERN BLOTTING;

EID: 84879932769     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Mercer JR, Cheng KK, Figg N, et al. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ Res 2010;107:1021-31.
2. Wu D, Yang H, Xiang W, et al. Heterozygous mutation of ataxiatelangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice. J Lipid Res 2005;46:1380-7.
3. Halaby MJ, Hibma JC, He J, Yang DQ. ATM protein kinase mediates full activation of Akt and regulates glucose transporter 4 translocation by insulin in muscle cells. Cell Signal 2008;20:1555-63.
4. Razani B, Feng C, Semenkovich CF. p53 is required for chloroquine-induced atheroprotection but not insulin sensitization. J Lipid Res 2010;51:1738-46.
5. Foster CR, Zha Q, Daniel LL, Singh M, Singh K. Lack of ataxia telangiectasia mutated kinase induces structural and functional changes in the heart: Role in beta-adrenergic receptor-stimulated apoptosis. Exp Physiol 2012;97:506-15.
6. DeBosch B, Sambandam N, Weinheimer C, Courtois M, Muslin AJ. Akt2 regulates cardiac metabolism and cardiomyocyte survival. J Biol Chem 2006;281:32841-51.
7. Yoshida M, Shiojima I, Ikeda H, Komuro I. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53- apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J Mol Cell Cardiol 2009;47:698-705.
8. Schneider JG, Finck BN, Ren J, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 2006;4:377-89.
9. Morris SJ, Wasko MC, Antohe JL, et al. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 2011;63:530-4.
10. Litwin SE, Katz SE, Morgan JP, Douglas PS. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 1994;89:345-54.
11. Golubnitschaja O. Cell cycle checkpoints: The role and evaluation for early diagnosis of senescence, cardiovascular, cancer, and neurodegenerative diseases. Amino Acids 2007;32:359-71.
12. Kato H, Takashima S, Asano Y, et al. Identification of p32 as a novel substrate for ATM in heart. Biochem Biophys Res Commun 2008;366:885-91.
13. Hammond EM, Dorie MJ, Giaccia AJ. ATR/ATM targets are phosphorylated by ATR in response to hypoxia and ATM in response to reoxygenation. J Biol Chem 2003; 278:12207-13.
14. Watters DJ. Oxidative stress in ataxia telangiectasia. Redox Rep 2003; 8:23-9.
15. Foster CR, Singh M, Subramanian V, Singh K. Ataxia telangiectasia mutated kinase plays a protective role in betaadrenergic receptor-stimulated cardiac myocyte apoptosis and myocardial remodeling. Mol Cell Biochem 2011;353:13-22.
16. Gorr MW, Stevens SC, Wold LE. Ataxia telangiectasia mutated kinase in the heart: Currency for myocyte apoptosis. Exp Physiol 2012;97:476.
17. Li G, Wang ZH, Zhu BB, Zhang CJ. Plasma uric acid is associated with postinfarction cardiac remodeling in elderly with old myocardial infarction. Int J Gerontol 2012;6:174-6.
18. Shackelford RE. Pharmacologic manipulation of the ataxiatelangiectasia mutated gene product as an intervention in age-related disease. Med Hypotheses 2005;65:363-9.
19. Shoelson SE. Banking on ATM as a new target in metabolic syndrome. Cell Metab 2006;4:337-8.